elranatamab,teclistamab
genmab,pfizer,janssen
['elranatamab', 'multiplemyeloma', 'teclistamab', 'jnjnews', 'pfizer']
two bcma-targeting bispecific antibodies from and teclistamab and elranatamab both have new data in later-line #multiplemyeloma therapy to chew over at #asco22 
https://t.co/O0ZJQGMjEP, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate